MedPath

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

Not Applicable
Completed
Conditions
Treatment Resistant Depression
Interventions
Registration Number
NCT04101474
Lead Sponsor
Assiut University
Brief Summary

In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.

Detailed Description

A Twice repetition of IV infusion of 0.5 mg/kg of ketamine produces an antidepressant response in individuals with treatment-resistant MDD

The work aims to:

1. To assess the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder.

2. To find out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  1. Patients fulfilling diagnostic criteria of treatment-resistant MDD.
  2. Presence of suicidal risk.
  3. No comorbid medical or neurological conditions.
  4. Age above 18 years old.
  5. Both gender.
  6. Informed written consent from the patient or his legitimate.
Exclusion Criteria
  1. Presence of perceptual disturbance.
  2. History of sensitivity to ketamine.
  3. Refusal to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ketamine groupKetamineThis group had ketamine
Primary Outcome Measures
NameTimeMethod
Role of Ketamine as Antidepressant1 year

the onset of action and degree of improvement and the duration of antidepressant effect of ketamine in a sample of patients with treatment -resistant major depressive disorder.

Effect of Ketamine on Suicidality1 year

finding out whether the onset of Ketamine antidepressant effect is associated with an improvement of suicidality in those patients

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath